http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106668860-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
filingDate | 2015-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106668860-B |
titleOfInvention | The delivery system and its preparation and preparation method of targeting posterior segment |
abstract | The present invention relates to field of pharmaceutical preparations, a kind of delivery system targeting posterior segment and its preparation and preparation method are specifically provided, system of the present invention includes the polymer of drug and dendritic, polyethylene glycol, RGD peptide and CPP peptide, wherein the dendritic is the polyamide-amine dendrimers in 3.0~10.0 generations, polyethylene glycol is the polyethylene glycol of 2000~5000Da molecular weight ranges, and RGD peptide is cyclic peptide.Drug can be effectively communicated to the diseased region of posterior segment by delivery system and its preparation of the present invention, reduce the damage of drug normal tissue, reduce patient's medication pain, and increase patient's compliance. |
priorityDate | 2015-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 148.